Cencora (NYSE:COR) Price Target Raised to $285.00

Posted by on Jun 24th, 2026

Cencora (NYSE:COR – Get Free Report) had its price target lifted by research analysts at Bank of America from $280.00 to $285.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Bank of America‘s price objective would indicate a potential downside of 0.79% from the stock’s current price.

Other equities research analysts have also issued reports about the stock. UBS Group upped their price objective on shares of Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Citigroup dropped their target price on shares of Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a report on Thursday, May 7th. Morgan Stanley set a $342.00 price target on shares of Cencora in a research report on Friday, May 8th. William Blair assumed coverage on shares of Cencora in a research report on Tuesday, April 28th. They set a “market perform” rating on the stock. Finally, Weiss Ratings downgraded Cencora from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, May 22nd. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $367.75.

Read Our Latest Analysis on COR

Cencora Trading Up 2.2%

Shares of Cencora stock traded up $6.18 during midday trading on Wednesday, reaching $287.28. The company had a trading volume of 549,312 shares, compared to its average volume of 1,534,117. The stock has a fifty day moving average price of $282.77 and a 200 day moving average price of $323.17. Cencora has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The firm has a market cap of $55.89 billion, a PE ratio of 22.03, a P/E/G ratio of 1.46 and a beta of 0.59. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59.

Cencora (NYSE:COR – Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm had revenue of $78.36 billion for the quarter, compared to analyst estimates of $81.09 billion. During the same period in the prior year, the company posted $4.42 EPS. The business’s revenue for the quarter was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, equities analysts anticipate that Cencora will post 17.79 earnings per share for the current year.

Cencora declared that its Board of Directors has initiated a stock repurchase program on Thursday, May 21st that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the company to buy up to 3.9% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its shares are undervalued.

Institutional Investors Weigh In On Cencora

A number of hedge funds have recently added to or reduced their stakes in the company. United Bank raised its stake in shares of Cencora by 4.5% in the second quarter. United Bank now owns 7,032 shares of the company’s stock worth $2,109,000 after purchasing an additional 305 shares during the last quarter. Nebula Research & Development LLC purchased a new position in shares of Cencora during the second quarter valued at approximately $595,000. Treasurer of the State of North Carolina grew its holdings in Cencora by 7.9% during the second quarter. Treasurer of the State of North Carolina now owns 85,534 shares of the company’s stock worth $25,647,000 after buying an additional 6,244 shares in the last quarter. Diversify Advisory Services LLC grew its holdings in Cencora by 94.1% during the second quarter. Diversify Advisory Services LLC now owns 2,585 shares of the company’s stock worth $747,000 after buying an additional 1,253 shares in the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its holdings in Cencora by 26.0% during the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 73,452 shares of the company’s stock worth $22,025,000 after buying an additional 15,154 shares in the last quarter. Institutional investors and hedge funds own 97.52% of the company’s stock.

Cencora Company Profile

(Get Free Report)

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.

See Also

Analyst Recommendations for Cencora (NYSE:COR)

Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.